St. Simmons et al., Insulin stimulation of glutamine: Fructose-6-phosphate amidotransferase occurs via an insulin-like growth factor-1 pathway in rat fibroblasts, RES COM M P, 104(1), 1999, pp. 63-72
Citations number
17
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
The biosynthetic pathway for hexosamine mediates some of the adverse effect
s of high glucose. The rate limiting enzyme in this pathway is glutamine :
fructose-6-phosphate amidotransferase (GFA). Using HPLC, the regulation of
GFA activity by glucose and insulin was studied in wild type and rat-1 fibr
oblasts overexpressing human insulin receptors (HIRcB cells). In wild type
cells only maximal doses of insulin (580 ng/ml) resulted in an increase in
GFA activity (51.0 +/- 40.6%). In HIRcB cells insulin led to a dose depende
nt increase in GFA activity that was enhanced when compared to wild type (8
9 +/- 5% (p<0.001) increase at 580 ng/ml). Insulin's action was glucose dep
endent and required prolonged serum deprivation. HIRcB's cultured in 0 mM g
lucose had a 58.2% (p<0.001) decrease in insulin stimulation. However, when
present the concentration of glucose (2-20 mM) did not affect insulin stim
ulation of GFA activity. Most of insulin's effects occur by way of the IGF-
I receptor as a two-fold stimulation of GFA activity was seen with signific
antly lower doses (10 ng/ml) of IGF-1. We conclude that GFA enzyme activity
is upregulated by insulin and this may occur via a IGF-1 receptor mediated
pathway.